Kelly Barfield
About Kelly Barfield
Kelly Barfield serves as the Director of National Accounts & Access Strategy at Deciphera Pharmaceuticals, where he has worked since 2022. He has extensive experience in the pharmaceutical industry, having held various roles at companies such as Salix Pharmaceuticals, Stiefel Laboratories, and Novo Nordisk.
Current Role at Deciphera Pharmaceuticals
Kelly Barfield serves as the Director of National Accounts & Access Strategy at Deciphera Pharmaceuticals. She has held this position since 2022 and is based in Carlsbad, California. In this role, she is responsible for developing strategies to enhance access to Deciphera's products across national accounts.
Previous Experience at Deciphera Pharmaceuticals
Prior to her current role, Kelly Barfield worked at Deciphera Pharmaceuticals as the Field Access Director from 2020 to 2022. During her tenure, she focused on improving access to the company's therapies and building relationships with key stakeholders in the healthcare sector.
Professional Background in Pharmaceuticals
Kelly Barfield has extensive experience in the pharmaceutical industry. She worked at Salix Pharmaceuticals in various roles, including Territory Manager from 2009 to 2011 and Western Regional Account Manager from 2011 to 2013. She also served as a Sales Representative at Stiefel Laboratories from 2003 to 2009 and as a BioPharm Account Executive at Novo Nordisk from 2014 to 2017.
Education and Academic Background
Kelly Barfield studied at California State University San Marcos, where she focused on Finance. She completed her studies in Business from 2000 to 2002, gaining foundational knowledge that supports her career in the pharmaceutical industry.
Experience in Corporate Accounts
From 2017 to 2020, Kelly Barfield worked as the Corporate Account Director at HEMA Biologics in the Greater San Diego Area. In this role, she managed corporate accounts and developed strategies to enhance business relationships and drive sales.